Perspective Therapeutics, Inc.(CATX)内部人交易:高管与董事近期交易
过去 18 个月,共有 8 位内部人为 Perspective Therapeutics, Inc.(CATX)报告了 22 笔 Form 4 交易(最近一笔 2026-11-19)。
| 日期 | 内部人 | 职务 | 类型 | 股数 | 市值 |
|---|---|---|---|---|---|
| 2026-11-19 | Williamson Robert F III | 董事 | 买入 | 15,000 | $12,000 |
| 2026-11-18 | Williamson Robert F III | 董事 | 买入 | 25,000 | $20,950 |
| 2026-11-17 | Morich Frank | 董事 | 买入 | 15,000 | $14,046 |
| 2026-11-16 | Woods Lori A | 董事 | 买入 | 23,750 | $20,040 |
| 2026-11-16 | Williamson Robert F III | 董事 | 买入 | 18,609 | $15,632 |
| 2026-11-16 | Morich Frank | 董事 | 买入 | 15,000 | $14,956 |
| 2026-11-16 | Williamson Robert F III | 董事 | 买入 | 6,289 | $5,274 |
| 2026-11-13 | Puhlmann Markus | Chief Medical Officer | 买入 | 6,000 | $4,980 |
| 2026-11-13 | Puhlmann Markus | Chief Medical Officer | 买入 | 35,000 | $29,564 |
| 2026-11-12 | Spoor Johan M. | Chief Executive Officer | 买入 | 47,000 | $37,943 |
| 2026-09-08 | Lantheus Holdings, Inc. | 10% 以上股东 | 卖出 | 80,783 | $251,235 |
| 2026-09-08 | Lantheus Alpha Therapy, LLC | 10% 以上股东 | 卖出 | 80,783 | $251,235 |
| 2026-09-08 | Lantheus Holdings, Inc. | 10% 以上股东 | 卖出 | 167,149 | $526,519 |
| 2026-09-08 | Lantheus Alpha Therapy, LLC | 10% 以上股东 | 卖出 | 167,149 | $526,519 |
| 2026-09-04 | Lantheus Holdings, Inc. | 10% 以上股东 | 卖出 | 42,129 | $131,021 |
| 2026-09-04 | Lantheus Alpha Therapy, LLC | 10% 以上股东 | 卖出 | 42,129 | $131,021 |
| 2026-09-04 | Lantheus Alpha Therapy, LLC | 10% 以上股东 | 卖出 | 78,145 | $245,375 |
| 2026-09-04 | Lantheus Alpha Therapy, LLC | 10% 以上股东 | 卖出 | 35,769 | $111,599 |
| 2026-09-03 | Lantheus Holdings, Inc. | 10% 以上股东 | 卖出 | 35,769 | $111,599 |
| 2026-09-02 | Lantheus Holdings, Inc. | 10% 以上股东 | 卖出 | 78,145 | $245,375 |
| 2025-11-17 | Hunt Jonathan Robert | Chief Accounting Officer | 买入 | 11,000 | $22,330 |
| 2025-11-14 | Williamson Robert F III | 董事 | 买入 | 9,498 | $19,946 |
来源:SEC Form 4 申报文件 · 截至 2026-11-19